L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 27 medicines in this group and its subgroups.
- 26 prescription only (POM)
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
-
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
- L01EG01 temsirolimus 1 medicine
- L01EG02 everolimus 26 medicines
-
L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
1 more subgroup has no medicine with a leaflet on this site.
Active substances in the group
- Everolimus 26 medicines
- Temsirolimus 1 medicine
Medicines in the group and its subgroups
Other groups of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 10 medicines
- L01EF Cyclin-dependent kinase (CDK) inhibitors 13 medicines
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 4 medicines
- L01EJ Janus-associated kinase (JAK) inhibitors 18 medicines
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 12 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01EX Other protein kinase inhibitors 94 medicines
Other names of the ATC group
- German: L01EG Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren
- German: L01EG Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren
- Italian: L01EG Inibitori chinasi target della rapamicina nei mamm.(mTOR)
- Turkish: L01EG Rapamisin (mTOR) kinaz inhibitörlerinin memeli hedefi
- Czech: L01EG Inhibitory mTOR (mammalian target of rapamycin) kinázy
- Slovak: L01EG Inhibítory kinázy cicavčieho cieľa rapamycínu (mTOR)
- German (Switzerland): L01EG Mammalian target of rapamycin (mTOR)-Kinase-Inhibitoren
- Italian (Switzerland): L01EG Inibitori chinasi target della rapamicina nei mamm.(mTOR)
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EG
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.